Tonix Pharmaceuticals Holding Corp. - notizie pubblicate 579 - letture 9.308
TONIX PHARMACEUTICALS HOLDING CORP.
Investor Presentation July 2024
Corporate presentation july 2024 nasdaq: tnxp version p0576 july 15, 2024 (doc 1469) © 2024 tonix pharmaceuticals holding corp. who we are tonix is committed to developing and mar ...
TONIX PHARMACEUTICALS HOLDING CORP.
Short Investor Presentation July 2024
Corporate presentation abbreviated july 2024 nasdaq: tnxp version p0578 july 15, 2024 (doc 1475) © 2024 tonix pharmaceuticals holding corp. who we are tonix is committed to develo ...
TONIX PHARMACEUTICALS HOLDING CORP.
TNX-102 SL for Fibromyalgia and Long COVID
Tnx-102 sl fibromyalgia, long covid, and acute stress disorder nasdaq: tnxp version p0577 july 15, 2024 (doc 1474) © 2024 tonix pharmaceuticals holding corp. tonmya (tnx-102 sl)* ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Proposed Public Offering Form 8 K
Tonix pharmaceuticals announces proposed public offering chatham, n.j., july 8, 2024 (globe newswire) -- tonix pharmaceuticals holding corp. (nasdaq: tnxp) ("tonix" or th ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Tonix pharmaceuticals announces closing of $4.0 million public offering july 10, 2024 4:30pm edt download as pdf chatham, n.j., july 10, 2024 (globe newswire) -- tonix pharmaceutic ...
TONIX PHARMACEUTICALS HOLDING CORP.
Supplemental Prospectus - Form 424B5
Filed pursuant to rule 424(b)(5) registration no. 333-266982 prospectus supplement (to prospectus dated august 26, 2022) 3,393,600 shares of common stock pre-funded warrants to pur ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
Tonix pharmaceuticals announces pricing of approximately $4.0 million public offering july 09, 2024 9:15am edt download as pdf chatham, n.j., july 09, 2024 (globe newswire) -- toni ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Proposed Public Offering
Tonix pharmaceuticals announces proposed public offering july 08, 2024 5:00pm edt download as pdf chatham, n.j., july 08, 2024 (globe newswire) -- tonix pharmaceuticals holding cor ...
TONIX PHARMACEUTICALS HOLDING CORP.
Supplemental Prospectus - Form 424B5
Filed pursuant to rule 424(b)(5) registration no. 333-266982 the information in this preliminary prospectus supplement is not complete and may be changed. this preliminary prospect ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Reports Final Positive Pre NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia Form 8 K
Tonix pharmaceuticals reports final positive pre-nda meeting with fda for tonmya™ for the management of fibromyalgia tonmya is a potential new first-line, centrally acting non-op ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
Tonix pharmaceuticals reports final positive pre-nda meeting with fda for tonmya™ for the management of fibromyalgia july 08, 2024 8:00am edt download as pdf tonmya is a potentia ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
Tonix pharmaceuticals awarded up to $34 million u.s. department of defense contract for accelerated development of broad-spectrum antiviral program july 01, 2024 8:00am edt downloa ...
TONIX PHARMACEUTICALS HOLDING CORP.
Material Agreement Form 8 K
Item 1.01 entry into a material definitive agreement. on june 28, 2024, tonix pharmaceuticals holding corp. (the "company") entered into an other transaction agreement (& ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Proposed Public Offering Form 8 K
Tonix pharmaceuticals announces proposed public offering chatham, n.j., june 26, 2024 (globe newswire) -- tonix pharmaceuticals holding corp. (nasdaq: tnxp) ("tonix" or t ...
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Tonix pharmaceuticals announces closing of $4.0 million public offering june 28, 2024 4:05pm edt download as pdf chatham, n.j., june 28, 2024 (globe newswire) -- tonix pharmaceutic ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti